NCT00236379View on ClinicalTrials.gov

A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder

PHASE4CompletedINTERVENTIONAL

Enrollment

59

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 2003

Conditions

SchizophreniaDiabetes Mellitus

Interventions

DRUG

Olanzapine

Target oral dose of 20 milligrams per day for 6 months

DRUG

Risperidone

Target oral dose of 6 milligrams per day for for 6 months

All Listed Sponsors

lead

Janssen, LP

INDUSTRY